Vaccines

The ACP says that staying up to date on vaccinations is more important than ever.

A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.

The deal is for the companies to supply up to 600 million doses of a MRNA-based vaccine candidate.

The candidate is a joint effort of Oxford University and AstraZeneca.

In a 45-person phase one clinical trial the vaccine subjects who received the vaccine candidate showed high neutralizing antibody responses.

For people who love cats but are allergic to them, relief may be on the horizon-and cats, rather than humans, would be the ones to be vaccinated.

Researchers are examining whether two adjuvants could help boost the power of flu vaccines.

There are a lot of options when it comes to flu vaccines, and now is the time to start thinking about-and better understanding-the differences

Vaccines can sometimes be a drain on practices. Mistakes in ordering, storing, or billing for vaccines can lead to losses. Here’s how to avoid these traps.

The survey, conducted for the American Osteopathic Association (AOA), identified three reasons for skepticism.

A new report reveals physicians have issues they need to resolve to move adult immunization forward.

A new study reveals that primary care offices are the best place to receive hepatitis vaccines, but more work is needed to improve timing.

Adult vaccination should be promoted as a way to improve health, rather than just avoid disease, according to a new report

CDC has issued a statement to put to rest the question of whether adults need a booster for measles protection

Mainstream media is raising the alarm on measles and posing a question about vaccine boosters. Are you ready to answer your patients’ questions?

The AAFP is mailing out new vaccine tables to help both clinicians and their patients understand the newest recommendations.

New tools to study the norovirus may lead to vaccines or even immunotherapy.

Report highlights physician preparedness, barriers for following pneumococcal vaccine guidance

Adult vaccination rates in the U.S. are low, and a new study offers insight on the consequences of missed vaccinations and how to close the gap.

The intranasal vaccine is back, and changes have been made to the viral composition of this year’s vaccine.

A new study details the use of bacteria to prevent PTSD, and possibly offer treatment for other stress disorders.

A new study reveals vaccine that could fight, prevent some cancers

There are many vaccines in development to fight Ebola, but few have been shown to have longevity-until now.

Vaccine hesitancy isn’t as much about additives, side effects, or organic parenting as it is about shifting societal trends toward distrust of medicine and a focus on one’s individual health, according to a new report.

Immune cells that previously were only known to play a role in harmful autoimmune processes may actually be useful in fighting hard-to-detect infections, according to a report.

Immunity wanes within a decade in 10 percent of patients vaccinated against pertussis.

A move to allow pharmacists to administer more vaccines could have a profound effect on adult vaccination rates and vaccine-preventable disease prevalence.

New vaccines that use antibodies to prevent opioids from causing a “high” could help stem abuse and fatal overdoses if human trials are successful.

Tracking, reporting, and organizing immunization-related data is difficult but can improve patient care. HIMSS has recognized several products through its voluntary testing program that can do that job and work with electronic health record systems.

A therapy that uses the immune system to fight cancer has been 97% effective in mice and is moving to human trials.